NO20023978D0 - 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, f.eks. anoreksimidler - Google Patents
8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, f.eks. anoreksimidlerInfo
- Publication number
- NO20023978D0 NO20023978D0 NO20023978A NO20023978A NO20023978D0 NO 20023978 D0 NO20023978 D0 NO 20023978D0 NO 20023978 A NO20023978 A NO 20023978A NO 20023978 A NO20023978 A NO 20023978A NO 20023978 D0 NO20023978 D0 NO 20023978D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- dihydroindo
- anorexia
- funds
- pharmaceuticals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Fuses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10008275 | 2000-02-23 | ||
| PCT/EP2001/001499 WO2001062746A1 (de) | 2000-02-23 | 2001-02-12 | 8,8a-DIHYDRO-INDENO[1,2-d]THIAZOL-DERIVATE, DIE IN 8a-STELLUNG SUBSTITUIERT SIND; VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL Z.B. ALS ANOREKTIKA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20023978D0 true NO20023978D0 (no) | 2002-08-21 |
| NO20023978L NO20023978L (no) | 2002-10-18 |
Family
ID=7631989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20023978A NO20023978L (no) | 2000-02-23 | 2002-08-21 | 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, for eksempel anoreksimidler |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US6403624B1 (no) |
| EP (1) | EP1259498B1 (no) |
| JP (1) | JP4898052B2 (no) |
| KR (1) | KR20020079891A (no) |
| CN (1) | CN1195747C (no) |
| AT (1) | ATE283265T1 (no) |
| AU (1) | AU781003B2 (no) |
| BR (1) | BR0108605A (no) |
| CA (1) | CA2400698A1 (no) |
| CZ (1) | CZ20022838A3 (no) |
| DE (1) | DE50104600D1 (no) |
| EE (1) | EE200200466A (no) |
| ES (1) | ES2231482T3 (no) |
| HK (1) | HK1055117A1 (no) |
| HR (1) | HRP20020688A2 (no) |
| HU (1) | HUP0300140A3 (no) |
| IL (1) | IL151327A0 (no) |
| MX (1) | MXPA02007021A (no) |
| NO (1) | NO20023978L (no) |
| NZ (1) | NZ520926A (no) |
| PL (1) | PL357547A1 (no) |
| PT (1) | PT1259498E (no) |
| RU (1) | RU2261860C2 (no) |
| SK (1) | SK12162002A3 (no) |
| WO (1) | WO2001062746A1 (no) |
| YU (1) | YU56302A (no) |
| ZA (1) | ZA200206487B (no) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10142660A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von Derivaten von C2-substituierten Indan-1-ol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| DE10142659A1 (de) | 2001-08-31 | 2003-03-20 | Aventis Pharma Gmbh | Verwendung von mehrfach substituierten Indan-1-ol. Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| EP2305352A1 (en) | 2004-04-02 | 2011-04-06 | Merck Sharp & Dohme Corp. | 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| CA2741125A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| US8329914B2 (en) | 2008-10-31 | 2012-12-11 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| JP2013520502A (ja) | 2010-02-25 | 2013-06-06 | メルク・シャープ・エンド・ドーム・コーポレイション | 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN105001219A (zh) | 2011-02-25 | 2015-10-28 | 默沙东公司 | 用作抗糖尿病药剂的新的环状氮杂苯并咪唑衍生物 |
| CN107090016A (zh) | 2011-03-01 | 2017-08-25 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| WO2014022528A1 (en) | 2012-08-02 | 2014-02-06 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| JP2016516004A (ja) | 2013-02-22 | 2016-06-02 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | 抗糖尿病二環式化合物 |
| EP2970119B1 (en) | 2013-03-14 | 2021-11-03 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| US10968232B2 (en) | 2016-12-20 | 2021-04-06 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2640358A1 (de) * | 1976-09-08 | 1978-03-16 | Hoechst Ag | Thiazolidinderivate und verfahren zu ihrer herstellung |
| GB9517381D0 (en) * | 1995-08-24 | 1995-10-25 | Pharmacia Spa | Aryl and heteroaryl piperazine derivatives |
| DE19844547C2 (de) * | 1998-09-29 | 2002-11-07 | Aventis Pharma Gmbh | Polycyclische Dihydrothiazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| DE19908539A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
-
2001
- 2001-02-12 KR KR1020027011001A patent/KR20020079891A/ko not_active Application Discontinuation
- 2001-02-12 AT AT01929342T patent/ATE283265T1/de not_active IP Right Cessation
- 2001-02-12 DE DE50104600T patent/DE50104600D1/de not_active Expired - Lifetime
- 2001-02-12 HU HU0300140A patent/HUP0300140A3/hu unknown
- 2001-02-12 EP EP01929342A patent/EP1259498B1/de not_active Expired - Lifetime
- 2001-02-12 NZ NZ520926A patent/NZ520926A/en unknown
- 2001-02-12 YU YU56302A patent/YU56302A/sh unknown
- 2001-02-12 MX MXPA02007021A patent/MXPA02007021A/es active IP Right Grant
- 2001-02-12 BR BR0108605-7A patent/BR0108605A/pt not_active IP Right Cessation
- 2001-02-12 ES ES01929342T patent/ES2231482T3/es not_active Expired - Lifetime
- 2001-02-12 CN CNB018054919A patent/CN1195747C/zh not_active Expired - Fee Related
- 2001-02-12 JP JP2001562528A patent/JP4898052B2/ja not_active Expired - Fee Related
- 2001-02-12 CA CA002400698A patent/CA2400698A1/en not_active Abandoned
- 2001-02-12 IL IL15132701A patent/IL151327A0/xx unknown
- 2001-02-12 WO PCT/EP2001/001499 patent/WO2001062746A1/de not_active Application Discontinuation
- 2001-02-12 SK SK1216-2002A patent/SK12162002A3/sk unknown
- 2001-02-12 RU RU2002125460/04A patent/RU2261860C2/ru not_active IP Right Cessation
- 2001-02-12 CZ CZ20022838A patent/CZ20022838A3/cs unknown
- 2001-02-12 PL PL01357547A patent/PL357547A1/xx not_active Application Discontinuation
- 2001-02-12 AU AU56153/01A patent/AU781003B2/en not_active Ceased
- 2001-02-12 EE EEP200200466A patent/EE200200466A/xx unknown
- 2001-02-12 PT PT01929342T patent/PT1259498E/pt unknown
- 2001-02-23 US US09/790,911 patent/US6403624B1/en not_active Expired - Lifetime
-
2002
- 2002-08-14 ZA ZA200206487A patent/ZA200206487B/en unknown
- 2002-08-21 NO NO20023978A patent/NO20023978L/no not_active Application Discontinuation
- 2002-08-22 HR HRP20020688 patent/HRP20020688A2/hr not_active Application Discontinuation
-
2003
- 2003-10-15 HK HK03107412A patent/HK1055117A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003528825A (ja) | 2003-09-30 |
| JP4898052B2 (ja) | 2012-03-14 |
| RU2002125460A (ru) | 2004-01-10 |
| EP1259498B1 (de) | 2004-11-24 |
| SK12162002A3 (sk) | 2003-02-04 |
| PT1259498E (pt) | 2005-02-28 |
| ATE283265T1 (de) | 2004-12-15 |
| RU2261860C2 (ru) | 2005-10-10 |
| EE200200466A (et) | 2003-12-15 |
| DE50104600D1 (de) | 2004-12-30 |
| HK1055117A1 (en) | 2003-12-24 |
| AU781003B2 (en) | 2005-04-28 |
| MXPA02007021A (es) | 2003-03-27 |
| IL151327A0 (en) | 2003-04-10 |
| CN1195747C (zh) | 2005-04-06 |
| CN1423640A (zh) | 2003-06-11 |
| US6403624B1 (en) | 2002-06-11 |
| AU5615301A (en) | 2001-09-03 |
| ES2231482T3 (es) | 2005-05-16 |
| BR0108605A (pt) | 2002-11-19 |
| NO20023978L (no) | 2002-10-18 |
| HUP0300140A2 (en) | 2003-05-28 |
| WO2001062746A1 (de) | 2001-08-30 |
| HRP20020688A2 (en) | 2004-12-31 |
| US20020058658A1 (en) | 2002-05-16 |
| KR20020079891A (ko) | 2002-10-19 |
| CA2400698A1 (en) | 2001-08-30 |
| YU56302A (sh) | 2005-11-28 |
| ZA200206487B (en) | 2003-10-16 |
| PL357547A1 (en) | 2004-07-26 |
| CZ20022838A3 (cs) | 2002-11-13 |
| NZ520926A (en) | 2004-08-27 |
| HUP0300140A3 (en) | 2004-10-28 |
| EP1259498A1 (de) | 2002-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20023978D0 (no) | 8,8A-dihydro-indeno(1,2-D)tiazolderivater, substituert i posisjon 8A, en fremgangsmåte for deres fremstilling og deresanvendelse som legemidler, f.eks. anoreksimidler | |
| DK1261593T3 (da) | 8,8a-Dihydro-indeno[1,2-d]thiazol-derivater med en sulfonamido- eller sulfonosubstituent i 2-stillingen, en fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel | |
| NO20062644L (no) | DPP-IV inhibitorer | |
| NO20054787L (no) | Indenderivater som farmasotiske midler | |
| GEP20094736B (en) | Prodrugs of piperazine and substituted piperidine antiviral agents | |
| NO308248B1 (no) | Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat | |
| ES2243579T3 (es) | Derivados de pirazolopirideno. | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| NO20061045L (no) | Imidazolderivater | |
| BR0215709A (pt) | Processo para a preparação de cefdinir | |
| YU76500A (sh) | Hemijska sinzeza morfolinskih derivata | |
| BR0008510A (pt) | Sistemas policìclicos de 2-amino-tiazol, processo para a sua preparação e medicamento contendo estes compostos | |
| HUP0104213A2 (hu) | Vankoreszmicin, eljárás előállítására és gyógyszerként történő alkalmazása | |
| HUP0401895A2 (hu) | Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| NO20023955L (no) | Substituerte 8,8a-dihydro-3aH-indeno[1,2-d]tiazoler, en fremgangsmåte for fremstilling og deres anvendelse sommedikamenter | |
| YU60401A (sh) | Postupak za dobijanje derivata bifenil-2-karboksilne kiseline | |
| NO20025031L (no) | Benzoksazin- og benzotiazinderivater og deres anvendelse i farmasöytiske midler | |
| BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
| UY26617A1 (es) | Derivados de 2-fenilpiran-4-ona |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |